AstraZeneca in $1.15B Deal for Pearl Therapeutics

AstraZeneca in $1.15B Deal for Pearl Therapeutics Play

June 10 (Bloomberg) -- Bloomberg's Anna Edwards reports that AstraZeneca has agreed to a $1.15 billion deal to buy Pearl Therapeutics, a maker of therapies for respiratory disease. She speaks on Bloomberg Television's "Countdown."

  • On Air Now

    Countdown Watch Now

  • Next

    On the Move with Rishaad Salamat

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

blog comments powered by Disqus